Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000985183 | SCV001521999 | pathogenic | Temtamy syndrome | 2019-12-10 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Center for Genomic Medicine, |
RCV000985183 | SCV004805049 | pathogenic | Temtamy syndrome | 2024-03-17 | criteria provided, single submitter | research | |
Lupski Lab, |
RCV000491421 | SCV000282204 | pathogenic | Global developmental delay; Hydronephrosis; Vesicoureteral reflux; Intellectual disability; Renal atrophy; Attention deficit hyperactivity disorder | 2016-01-10 | no assertion criteria provided | research | |
Biochemical Molecular Genetic Laboratory, |
RCV000985183 | SCV001133198 | pathogenic | Temtamy syndrome | 2019-09-26 | no assertion criteria provided | clinical testing |